Proton Intelligence Inc., a Vancouver, Canada-based developer of a steady potassium monitoring (CKM™) platform, closed a $6.95m USD seed financing spherical.
Backers included SOSV, We Enterprise Capital, Tenmile, LongeVC, fifteenth Rock, Exor, and Trampoline Enterprise Companions.
Led by Dr. Sahan Ranamukhaarachchi, Founder and CEO, Proton Intelligence offers the CKM™ platform, which is designed to rework the administration of cardio-kidney-metabolic illnesses by offering clinicians and sufferers with information about potassium ranges on-demand. Proton’s CKM™ know-how goals to offer suppliers and sufferers correct, distant, steady potassium ranges permitting exact remedy of sufferers affected by kidney illness or coronary heart failure.
Proton Intelligence has initiated scientific research assessing the efficiency of CKM™ in individuals residing with severely impaired kidney operate such because the underserved inhabitants residing with end-stage renal illness (ESRD) or power kidney illness (CKD).
The corporate is headquartered in Vancouver, Canada, with R&D operations in Melbourne, Australia.
FinSMEs
02/01/2025
